Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Eileanoir Johnson is active.

Publication


Featured researches published by Eileanoir Johnson.


Neuropsychologia | 2015

The impact of occipital lobe cortical thickness on cognitive task performance: An investigation in Huntington's Disease.

Eileanoir Johnson; Em Rees; Izelle Labuschagne; Alexandra Durr; Blair R. Leavitt; Raymund A.C. Roos; Ralf Reilmann; Hans J. Johnson; Nicola Z. Hobbs; Douglas R. Langbehn; Julie C. Stout; Sarah J. Tabrizi; Rachael I. Scahill

BACKGROUND The occipital lobe is an important visual processing region of the brain. Following consistent findings of early neural changes in the occipital lobe in Huntingtons Disease (HD), we examined cortical thickness across four occipital regions in premanifest (preHD) and early HD groups compared with controls. Associations between cortical thickness in gene positive individuals and performance on six cognitive tasks, each with a visual component, were examined. In addition, the association between cortical thickness in gene positive participants and one non-visual motor task was also examined for comparison. METHODS Cortical thickness was determined using FreeSurfer on T1-weighted 3T MR datasets from controls (N=97), preHD (N=109) and HD (N=69) from the TRACK-HD study. Regression models were fitted to assess between-group differences in cortical thickness, and relationships between performance on the cognitive tasks, the motor task and occipital thickness were examined in a subset of gene-positive participants (N=141). RESULTS Thickness of the occipital cortex in preHD and early HD participants was reduced compared with controls. Regionally-specific associations between reduced cortical thickness and poorer performance were found for five of the six cognitive tasks, with the strongest associations in lateral occipital and lingual regions. No associations were found with the cuneus. The non-visual motor task was not associated with thickness of any region. CONCLUSIONS The heterogeneous pattern of associations found in the present study suggests that occipital thickness negatively impacts cognition, but only in regions that are linked to relatively advanced visual processing (e.g., lateral occipital, lingual regions), rather than in basic visual processing regions such as the cuneus. Our results show, for the first time, the functional implications of occipital atrophy highlighted in recent studies in HD.


Frontiers in Neurology | 2017

Recommendations for the Use of Automated Gray Matter Segmentation Tools: Evidence from Huntington’s Disease

Eileanoir Johnson; Sarah Gregory; Hans J. Johnson; Alexandra Durr; Blair R. Leavitt; Raymund A.C. Roos; Geraint Rees; Sarah J. Tabrizi; Rachael I. Scahill

The selection of an appropriate segmentation tool is a challenge facing any researcher aiming to measure gray matter (GM) volume. Many tools have been compared, yet there is currently no method that can be recommended above all others; in particular, there is a lack of validation in disease cohorts. This work utilizes a clinical dataset to conduct an extensive comparison of segmentation tools. Our results confirm that all tools have advantages and disadvantages, and we present a series of considerations that may be of use when selecting a GM segmentation method, rather than a ranking of these tools. Seven segmentation tools were compared using 3 T MRI data from 20 controls, 40 premanifest Huntington’s disease (HD), and 40 early HD participants. Segmented volumes underwent detailed visual quality control. Reliability and repeatability of total, cortical, and lobular GM were investigated in repeated baseline scans. The relationship between each tool was also examined. Longitudinal within-group change over 3 years was assessed via generalized least squares regression to determine sensitivity of each tool to disease effects. Visual quality control and raw volumes highlighted large variability between tools, especially in occipital and temporal regions. Most tools showed reliable performance and the volumes were generally correlated. Results for longitudinal within-group change varied between tools, especially within lobular regions. These differences highlight the need for careful selection of segmentation methods in clinical neuroimaging studies. This guide acts as a primer aimed at the novice or non-technical imaging scientist providing recommendations for the selection of cohort-appropriate GM segmentation software.


JCI insight | 2017

Topological length of white matter connections predicts their rate of atrophy in premanifest Huntington’s disease

Peter McColgan; Kiran K. Seunarine; Sarah Gregory; Adeel Razi; Marina Papoutsi; Jeffrey D. Long; James A. Mills; Eileanoir Johnson; Alexandra Durr; Raymund A.C. Roos; Blair R. Leavitt; Julie C. Stout; Rachael I. Scahill; Chris A. Clark; Geraint Rees; Sarah J. Tabrizi

We lack a mechanistic explanation for the stereotyped pattern of white matter loss seen in Huntington’s disease (HD). While the earliest white matter changes are seen around the striatum, within the corpus callosum, and in the posterior white matter tracts, the order in which these changes occur and why these white matter connections are specifically vulnerable is unclear. Here, we use diffusion tractography in a longitudinal cohort of individuals yet to develop clinical symptoms of HD to identify a hierarchy of vulnerability, where the topological length of white matter connections between a brain area and its neighbors predicts the rate of atrophy over 24 months. This demonstrates a new principle underlying neurodegeneration in HD, whereby brain connections with the greatest topological length are the first to suffer damage that can account for the stereotyped pattern of white matter loss observed in premanifest HD.


Neurology | 2018

Neurofilament light protein in blood predicts regional atrophy in Huntington disease

Eileanoir Johnson; Lauren M. Byrne; Sarah Gregory; Filipe B. Rodrigues; Kaj Blennow; Alexandra Durr; Blair R. Leavitt; Raymund A.C. Roos; Henrik Zetterberg; Sarah J. Tabrizi; Rachael I. Scahill; Edward J. Wild

Objective Neurofilament light (NfL) protein in blood plasma has been proposed as a prognostic biomarker of neurodegeneration in a number of conditions, including Huntington disease (HD). This study investigates the regional distribution of NfL-associated neural pathology in HD gene expansion carriers. Methods We examined associations between NfL measured in plasma and regionally specific atrophy in cross-sectional (n = 198) and longitudinal (n = 177) data in HD gene expansion carriers from the international multisite TRACK-HD study. Using voxel-based morphometry, we measured associations between baseline NfL levels and both baseline gray matter and white matter volume; and longitudinal change in gray matter and white matter over the subsequent 3 years in HD gene expansion carriers. Results After controlling for demographics, associations between increased NfL levels and reduced brain volume were seen in cortical and subcortical gray matter and within the white matter. After also controlling for known predictors of disease progression (age and CAG repeat length), associations were limited to the caudate and putamen. Longitudinally, NfL predicted subsequent occipital gray matter atrophy and widespread white matter reduction, both before and after correction for other predictors of disease progression. Conclusions These findings highlight the value of NfL as a dynamic marker of brain atrophy and, more generally, provide further evidence of the strong association between plasma NfL level, a candidate blood biomarker, and pathologic neuronal change.


The Journal of Neuroscience | 2015

MEG Adaptation Resolves the Spatiotemporal Characteristics of Face-Sensitive Brain Responses

Michael I.G. Simpson; Sam R. Johnson; Garreth Prendergast; Athanasios V. Kokkinakis; Eileanoir Johnson; Gary G. R. Green; Patrick Johnston

An unresolved goal in face perception is to identify brain areas involved in face processing and simultaneously understand the timing of their involvement. Currently, high spatial resolution imaging techniques identify the fusiform gyrus as subserving processing of invariant face features relating to identity. High temporal resolution imaging techniques localize an early latency evoked component—the N/M170—as having a major generator in the fusiform region; however, this evoked component is not believed to be associated with the processing of identity. To resolve this, we used novel magnetoencephalographic beamformer analyses to localize cortical regions in humans spatially with trial-by-trial activity that differentiated faces and objects and to interrogate their functional sensitivity by analyzing the effects of stimulus repetition. This demonstrated a temporal sequence of processing that provides category-level and then item-level invariance. The right fusiform gyrus showed adaptation to faces (not objects) at ∼150 ms after stimulus onset regardless of face identity; however, at the later latency of ∼200–300 ms, this area showed greater adaptation to repeated identity faces than to novel identities. This is consistent with an involvement of the fusiform region in both early and midlatency face-processing operations, with only the latter showing sensitivity to invariant face features relating to identity. SIGNIFICANCE STATEMENT Neuroimaging techniques with high spatial-resolution have identified brain structures that are reliably activated when viewing faces and techniques with high temporal resolution have identified the time-varying temporal signature of the brains response to faces. However, until now, colocalizing face-specific mechanisms in both time and space has proven notoriously difficult. Here, we used novel magnetoencephalographic analysis techniques to spatially localize cortical regions with trial-by-trial temporal activity that differentiates between faces and objects and to interrogate their functional sensitivity by analyzing effects of stimulus repetition on the time-locked signal. These analyses confirm a role for the right fusiform region in early to midlatency responses consistent with face identity processing and convincingly deliver upon magnetoencephalographys promise to resolve brain signals in time and space simultaneously.


Frontiers in Human Neuroscience | 2015

Detection of motor changes in huntington's disease using dynamic causal modeling

Lora Minkova; Elisa Scheller; Jessica Peter; Ahmed Abdulkadir; Christoph P. Kaller; Raymund A.C. Roos; Alexandra Durr; Blair R. Leavitt; Sarah J. Tabrizi; Stefan Klöppel; TrackOn-HD Investigators; Allison Coleman; Joji Decolongon; Mannie Fan; T. Koren; Céline Jauffret; Damian Justo; Stéphane Lehéricy; K. Nigaud; Romain Valabregue; A. Schoonderbeek; P. E. ‘t Hart; He Crawford; Sarah Gregory; D. J. Hensman Moss; Eileanoir Johnson; J Read; G Owen; Marina Papoutsi; C. Berna

Deficits in motor functioning are one of the hallmarks of Huntingtons disease (HD), a genetically caused neurodegenerative disorder. We applied functional magnetic resonance imaging (fMRI) and dynamic causal modeling (DCM) to assess changes that occur with disease progression in the neural circuitry of key areas associated with executive and cognitive aspects of motor control. Seventy-seven healthy controls, 62 pre-symptomatic HD gene carriers (preHD), and 16 patients with manifest HD symptoms (earlyHD) performed a motor finger-tapping fMRI task with systematically varying speed and complexity. DCM was used to assess the causal interactions among seven pre-defined regions of interest, comprising primary motor cortex, supplementary motor area (SMA), dorsal premotor cortex, and superior parietal cortex. To capture heterogeneity among HD gene carriers, DCM parameters were entered into a hierarchical cluster analysis using Wards method and squared Euclidian distance as a measure of similarity. After applying Bonferroni correction for the number of tests, DCM analysis revealed a group difference that was not present in the conventional fMRI analysis. We found an inhibitory effect of complexity on the connection from parietal to premotor areas in preHD, which became excitatory in earlyHD and correlated with putamen atrophy. While speed of finger movements did not modulate the connection from caudal to pre-SMA in controls and preHD, this connection became strongly negative in earlyHD. This second effect did not survive correction for multiple comparisons. Hierarchical clustering separated the gene mutation carriers into three clusters that also differed significantly between these two connections and thereby confirmed their relevance. DCM proved useful in identifying group differences that would have remained undetected by standard analyses and may aid in the investigation of between-subject heterogeneity.


Scientific Reports | 2018

Cerebrospinal fluid neurogranin and TREM2 in Huntington’s disease

Lauren M. Byrne; Filipe B. Rodrigues; Eileanoir Johnson; Enrico De Vita; Kaj Blennow; Rachael I. Scahill; Henrik Zetterberg; Amanda Heslegrave; Edward J. Wild

Biomarkers of Huntington’s disease (HD) in cerebrospinal fluid (CSF) could be of value in elucidating the biology of this genetic neurodegenerative disease, as well as in the development of novel therapeutics. Deranged synaptic and immune function have been reported in HD, and concentrations of the synaptic protein neurogranin and the microglial protein TREM2 are increased in other neurodegenerative diseases. We therefore used ELISAs to quantify neurogranin and TREM2 in CSF samples from HD mutation carriers and controls. CSF neurogranin concentration was not significantly altered in HD compared to controls, nor was it significantly associated with disease burden score, total functional capacity or motor score. An apparent increase in CSF TREM2 in manifest HD was determined to be due to increasing TREM2 with age. After age adjustment, there was no significant alteration of TREM2 in either HD group, nor any association with motor, functional or cognitive score, or brain volume quantified by MRI. Both analyses were well-powered, and sample size calculations indicated that several thousand samples per group would be needed to prove that disease-associated alterations do in fact exist. We conclude that neither neurogranin nor TREM2 is a useful biofluid biomarker for disease processes in Huntington’s disease.


Annals of clinical and translational neurology | 2018

An image‐based model of brain volume biomarker changes in Huntington's disease

P. A. Wijeratne; Alexandra L. Young; Neil P. Oxtoby; Razvan Valentin Marinescu; Nicholas C. Firth; Eileanoir Johnson; Amrita Mohan; Cristina Sampaio; Rachael I. Scahill; Sarah J. Tabrizi; Daniel C. Alexander

Determining the sequence in which Huntingtons disease biomarkers become abnormal can provide important insights into the disease progression and a quantitative tool for patient stratification. Here, we construct and present a uniquely fine‐grained model of temporal progression of Huntingtons disease from premanifest through to manifest stages.


Biological Psychiatry | 2017

Brain Regions Showing White Matter Loss in Huntington's Disease Are Enriched for Synaptic and Metabolic Genes

Peter McColgan; Sarah Gregory; Kiran K. Seunarine; Adeel Razi; Marina Papoutsi; Eileanoir Johnson; Alexandra Durr; Raymund A.C. Roos; Blair R. Leavitt; Peter Holmans; Rachael I. Scahill; Chris A. Clark; Geraint Rees; Sarah J. Tabrizi; Allison Coleman; Joji Decolongon; Mannie Fan; Terri L. Petkau; C. Jauffret; D. Justo; Stéphane Lehéricy; K. Nigaud; Romain Valabregue; A. Schoonderbeek; Ellen P. Hart; D. J. Hensman Moss; R. Ghosh; He Crawford; M. Papoutsi; C. Berna

Background The earliest white matter changes in Huntington’s disease are seen before disease onset in the premanifest stage around the striatum, within the corpus callosum, and in posterior white matter tracts. While experimental evidence suggests that these changes may be related to abnormal gene transcription, we lack an understanding of the biological processes driving this regional vulnerability. Methods Here, we investigate the relationship between regional transcription in the healthy brain, using the Allen Institute for Brain Science transcriptome atlas, and regional white matter connectivity loss at three time points over 24 months in subjects with premanifest Huntington’s disease relative to control participants. The baseline cohort included 72 premanifest Huntington’s disease participants and 85 healthy control participants. Results We show that loss of corticostriatal, interhemispheric, and intrahemispheric white matter connections at baseline and over 24 months in premanifest Huntington’s disease is associated with gene expression profiles enriched for synaptic genes and metabolic genes. Corticostriatal gene expression profiles are predominately associated with motor, parietal, and occipital regions, while interhemispheric expression profiles are associated with frontotemporal regions. We also show that genes with known abnormal transcription in human Huntington’s disease and animal models are overrepresented in synaptic gene expression profiles, but not in metabolic gene expression profiles. Conclusions These findings suggest a dual mechanism of white matter vulnerability in Huntington’s disease, in which abnormal transcription of synaptic genes and metabolic disturbance not related to transcription may drive white matter loss.


bioRxiv | 2018

Stability and sensitivity of structural connectomes: effect of thresholding and filtering and demonstration in neurodegeneration

Peter McColgan; Tessel Blom; Geraint Rees; Kiran K. Seunarine; Sarah Gregory; Eileanoir Johnson; Alexandra Durr; Raymund A.C. Roos; Rachael I. Scahill; Chris A. Clark; Sarah J. Tabrizi; Adeel Razi

Structural connectomes derived using diffusion tractography are increasingly used to investigate white matter connectivity in neurological diseases. However inherent biases in diffusion tractography algorithms may lead to both false negatives and false positives in connectome construction. A range of graph thresholding approaches and more recently several streamline filtering algorithms have been developed to address these issues. However there is no consensus in the literature regarding the best available approach. Using a cohort of Huntington’s disease patients and healthy controls we compared the effect of several graph thresholding strategies: proportional, absolute, consensus and consistency thresholding, with and without streamline filtering, using Spherical Deconvolution Informed Filtering of tractograms (SIFT2) algorithm. We examined the effect of thresholding strategies on the stability of graph theory metrics and the sensitivity of these measures in neurodegeneration. We show that while a number of graph thresholding procedures result in stable metrics across thresholds, the detection of group differences is highly variable. We also showed that the application of streamline filtering using SIFT2 resultes in better detection of group differences and stronger clinical correlations. We therefore conclude that the application of SIFT2 streamline filtering without graph thresholding may be sufficient for structural connectome construction.

Collaboration


Dive into the Eileanoir Johnson's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sarah J. Tabrizi

UCL Institute of Neurology

View shared research outputs
Top Co-Authors

Avatar

Blair R. Leavitt

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sarah Gregory

Wellcome Trust Centre for Neuroimaging

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Geraint Rees

University College London

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Adeel Razi

Wellcome Trust Centre for Neuroimaging

View shared research outputs
Top Co-Authors

Avatar

C. Berna

University College London

View shared research outputs
Researchain Logo
Decentralizing Knowledge